IYH:ARCA-iShares U.S. Healthcare

ETF | Health | NYSE Arca

Last Closing Price

USD 183.14


+0.62 (+0.34)%

Market Cap

USD 2.04B



Yahoo Analyst Target


STA Analyst Target

Yahoo Analyst Rating


STA Analyst Rating


STA Verdict



The investment seeks to track the investment results of Dow Jones U.S. Health Care Index composed of U.S. equities in the healthcare sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.

Inception Date: 12/06/2000

Primary Benchmark: DJ US Health Care TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.44%

Management Expense Ratio: 0.44 %

Unadjusted Closing Price

Adjusted Closing Price



Top Sectors


Top Regions


Share Volume

Relative Performance (Total Returns)

Relative Returns (From:    To: 2018-01-16 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV SPDR Select Sector Fund - Heal.. 0.14 %

+0.43 (+0.50%)

USD 17.56B
VHT Vanguard Health Care 0.10 %

+0.25 (+0.15%)

USD 7.51B
XBI SPDR Series Trust S&P Biotech 0.35 %

-2.78 (-3.10%)

USD 4.61B
IXJ iShares Global Healthcare 0.48 %

+0.06 (+0.05%)

USD 1.70B
IHI iShares U.S. Medical Devices 0.44 %

-0.58 (-0.32%)

USD 1.58B
FBT First Trust Amex Biotech Index.. 0.56 %

-2.94 (-2.22%)

USD 1.28B
FXH First Trust Health Care AlphaD.. 0.62 %

-0.34 (-0.46%)

USD 1.04B
HQH Tekla Healthcare Investors 0.00 %

-0.10 (-0.42%)

USD 0.97B
FHLC Fidelity MSCI Health Care Inde.. 0.08 %

+0.09 (+0.21%)

USD 0.97B
THQ Tekla Healthcare Opportunies F.. 0.00 %

-0.03 (-0.17%)

USD 0.78B

ETFs Containing IYH

RXD ProShares UltraShort Heal.. 0.88 % 0.95 %

-0.48 (-1.73%)

USD 0.98M

Market Performance

  Market Performance vs.
Industry/Classification (Health)
Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Capital Gain 5.11% 64% D 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.11% 64% D 77% C+
Trailing 12 Months  
Capital Gain 23.35% 61% D- 75% C
Dividend Return 1.29% 50% F 16% F
Total Return 24.64% 57% F 73% C
Trailing 5 Years  
Capital Gain 109.73% 60% D- 84% B
Dividend Return 11.01% 70% C- 32% F
Total Return 120.75% 60% D- 84% B
Average Annual (5 Year Horizon)  
Capital Gain 13.12% 68% D+ 82% B-
Dividend Return 14.59% 68% D+ 81% B-
Total Return 1.47% 68% D+ 27% F
Risk Return Profile  
Volatility (Standard Deviation) 12.91% 68% D+ 58% F
Risk Adjusted Return 112.98% 82% B- 85% B
Market Capitalization 1.71B 89% B+ 64% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike